Cargando…

Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits

PURPOSE: To describe the pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits. METHODS: The right eye of 20 rabbits was injected intravitreally with 1.25 mg/0.05 mL bevacizumab. Both eyes of four rabbits each time were enucleated at days 1, 3, 8, 15, and 29. Bevacizumab concentration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinapis, Christos I, Routsias, John G, Sinapis, Angelos I, Sinapis, Dimitrios I, Agrogiannis, George D, Pantopoulou, Alkistis, Theocharis, Stamatis E, Baltatzis, Stefanos, Patsouris, Efstratios, Perrea, Despoina
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104800/ https://www.ncbi.nlm.nih.gov/pubmed/21629577 http://dx.doi.org/10.2147/OPTH.S19555

Ejemplares similares

Biomechanical parameters of the cornea measured with the Ocular Response Analyzer in normal eyes
por: Kotecha, Aachal, et al.
Publicado: (2014)

Impact of Intravitreal Injection of Bevacizumab (Avastin) on Rabbit's Choroid and Retina
por: Karawya, Sherif, et al.
Publicado: (2008)

Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
por: Mandal, Subrata, et al.
Publicado: (2011)

Using intravitreal bevacizumab (Avastin(®)) – Indian Scenario
por: Kumar, Atul, et al.
Publicado: (2017)

Intravitreal Bevacizumab (Avastin) as an Adjuvant for the Treatment of Posterior Scleritis
por: Lim, Ji Won, et al.
Publicado: (2011)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
por: Sachdev, Nishant, et al.
Publicado: (2007)

Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
por: Arevalo, J. Fernando, et al.
Publicado: (2011)

Intravitreal Bevacizumab (Avastin) as an Adjuvant Treatment in Cases of Neovascular Glaucoma
por: Ghanem, Asaad A., et al.
Publicado: (2009)

Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
por: Karimi, Saeed, et al.
Publicado: (2020)

Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated
por: Shoaib, Khawaja K, et al.
Publicado: (2023)

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)

Acute Bilateral Endophthalmitis Following Bilateral Intravitreal Bevacizumab (Avastin) Injection
por: Tabatabaii, Ali, et al.
Publicado: (2013)

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
por: Kumar, Atul, et al.
Publicado: (2007)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)

Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario
por: Jain, Prashant, et al.
Publicado: (2017)

Is monthly retreatment with intravitreal bevacizumab (Avastin(®)) necessary in neovascular age-related macular degeneration?
por: Ghazi, Nicola G, et al.
Publicado: (2010)

A Prospective, Randomized Comparison of Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab (Avastin) in Diffuse Diabetic Macular Edema
por: Shahin, Maha M., et al.
Publicado: (2010)

The effect of intravitreal bevacizumab (Avastin(®)) on ocular pulse amplitude in neovascular age-related macular degeneration
por: Rechtman, Ehud, et al.
Publicado: (2011)

Long-Term Use of Intravitreal Bevacizumab (Avastin) for the Treatment of Von Hippel-Lindau Associated Retinal Hemangioblastomas
por: Hrisomalos, Frank N, et al.
Publicado: (2010)

Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin(®)) for AMD followed by controlateral sympathetic ophthalmia
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Water Soluble Vitamin E Administration in Wistar Rats with Non-alcoholic Fatty Liver Disease
por: Tzanetakou, Irene P, et al.
Publicado: (2012)

Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials
por: Qazi, Hammad A.
Publicado: (2012)

Comparative antilipidemic effect of N-acetylcysteine and sesame oil administration in diet-induced hypercholesterolemic mice
por: Korou, Laskarina-Maria, et al.
Publicado: (2010)

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
por: Shah, Parag K, et al.
Publicado: (2011)

Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells
por: Merz, Patrick R., et al.
Publicado: (2018)

Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes
por: Adrean, Sean D., et al.
Publicado: (2017)

Intravitreal Avastin for Choroidal Neovascularization Associated with Stargardt-Like Retinal Abnormalities in Pseudoxanthoma Elasticum
por: Querques, Giuseppe, et al.
Publicado: (2010)

Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy
por: Zaman, Yawar, et al.
Publicado: (2013)

Outcome of intravitreal Avastin® injections in patients with macular oedema in Uganda: a cohort study
por: Kabunga, Rachel R., et al.
Publicado: (2022)

Proteins from Avastin® (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear
por: Wan, Jia, et al.
Publicado: (2012)

Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization
por: Chen, Wei-Li, et al.
Publicado: (2014)

Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes
por: Lashay, Alireza, et al.
Publicado: (2020)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
por: Amit, Limor, et al.
Publicado: (2013)

Intralesional Bevacizumab (Avastin(®)) as a Novel Addition to Infantile Hemangioma Management: A Medical Hypothesis
por: Pourazizi, Mohsen, et al.
Publicado: (2017)

Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab
por: Kaplan, Richard I, et al.
Publicado: (2017)

Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin(®)) in patients with advanced non-squamous non-small cell lung cancer
por: Li, Cheryl S. W., et al.
Publicado: (2019)

Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
por: Raghuram, A, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_2ddb5e5v7o7pq2t5fqivq0anf6